Novel motif:32: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ |
Latest revision as of 14:40, 9 September 2013
name: | motif32_TRGNMCTNNT |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0043589 | skin morphogenesis | 7.859515e-56 |
GO:0070208 | protein heterotrimerization | 8.679309e-51 |
GO:0032964 | collagen biosynthetic process | 4.073815e-49 |
GO:0070206 | protein trimerization | 6.095474e-40 |
GO:0034505 | tooth mineralization | 3.363551e-38 |
GO:0030199 | collagen fibril organization | 1.559417e-37 |
GO:0032963 | collagen metabolic process | 2.017287e-31 |
GO:0030198 | extracellular matrix organization | 1.058597e-30 |
GO:0001957 | intramembranous ossification | 1.417197e-30 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 1.566640e-30 |
GO:0071230 | cellular response to amino acid stimulus | 2.015949e-30 |
GO:0001101 | response to acid | 1.774055e-29 |
GO:0071229 | cellular response to acid | 4.370718e-29 |
GO:0060346 | bone trabecula formation | 6.368469e-29 |
GO:0071418 | cellular response to amine stimulus | 2.030101e-28 |
GO:0044236 | multicellular organismal metabolic process | 2.144386e-28 |
GO:0071417 | cellular response to organic nitrogen | 4.442446e-28 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 2.124309e-27 |
GO:0043588 | skin development | 1.038354e-25 |
GO:0048730 | epidermis morphogenesis | 1.240667e-25 |
GO:0043200 | response to amino acid stimulus | 1.380638e-25 |
GO:0030277 | maintenance of gastrointestinal epithelium | 4.550694e-25 |
GO:0010669 | epithelial structure maintenance | 6.644554e-23 |
GO:0006342 | chromatin silencing | 2.908229e-21 |
GO:0060343 | trabecula formation | 1.987936e-20 |
GO:0061383 | trabecula morphogenesis | 2.078114e-20 |
GO:0001958 | endochondral ossification | 2.103658e-20 |
GO:0030261 | chromosome condensation | 2.728314e-20 |
GO:0051291 | protein heterooligomerization | 1.998957e-19 |
GO:0014075 | response to amine stimulus | 1.063307e-18 |
GO:0071300 | cellular response to retinoic acid | 8.601127e-18 |
GO:0045814 | negative regulation of gene expression, epigenetic | 8.899962e-18 |
GO:0042476 | odontogenesis | 1.251721e-17 |
GO:0007411 | axon guidance | 3.010795e-17 |
GO:0071299 | cellular response to vitamin A | 5.512945e-17 |
GO:0060350 | endochondral bone morphogenesis | 1.779722e-16 |
GO:0022600 | digestive system process | 2.368919e-16 |
GO:0030168 | platelet activation | 4.445268e-16 |
GO:0006935 | chemotaxis | 6.391694e-16 |
GO:0065008 | regulation of biological quality | 2.472404e-15 |
GO:0032989 | cellular component morphogenesis | 2.627762e-15 |
GO:0033189 | response to vitamin A | 7.418028e-15 |
GO:0009605 | response to external stimulus | 9.294273e-15 |
GO:0007409 | axonogenesis | 9.684998e-15 |
GO:0050690 | regulation of defense response to virus by virus | 1.401854e-14 |
GO:0031175 | neuron projection development | 1.534522e-14 |
GO:0032526 | response to retinoic acid | 3.693154e-14 |
GO:0071295 | cellular response to vitamin | 3.825137e-14 |
GO:0009612 | response to mechanical stimulus | 4.387189e-14 |
GO:0048812 | neuron projection morphogenesis | 7.831128e-14 |
GO:0031960 | response to corticosteroid stimulus | 1.625332e-13 |
GO:0010243 | response to organic nitrogen | 1.893231e-13 |
GO:0048858 | cell projection morphogenesis | 3.618416e-13 |
GO:0032990 | cell part morphogenesis | 3.686754e-13 |
GO:0010812 | negative regulation of cell-substrate adhesion | 4.265224e-13 |
GO:0048667 | cell morphogenesis involved in neuron differentiation | 5.050657e-13 |
GO:0033273 | response to vitamin | 5.799812e-13 |
GO:0048739 | cardiac muscle fiber development | 1.150563e-12 |
GO:0010770 | positive regulation of cell morphogenesis involved in differentiation | 1.287713e-12 |
GO:0010718 | positive regulation of epithelial to mesenchymal transition | 1.596114e-12 |
GO:0090263 | positive regulation of canonical Wnt receptor signaling pathway | 1.730694e-12 |
GO:0040011 | locomotion | 4.339840e-12 |
GO:0042396 | phosphagen biosynthetic process | 5.777879e-12 |
GO:0031214 | biomineral tissue development | 7.449624e-12 |
GO:0031670 | cellular response to nutrient | 7.466187e-12 |
GO:0001775 | cell activation | 8.705226e-12 |
GO:0030030 | cell projection organization | 1.713943e-11 |
GO:0043206 | fibril organization | 2.507434e-11 |
GO:0007586 | digestion | 3.203423e-11 |
GO:0048666 | neuron development | 3.587483e-11 |
GO:0050896 | response to stimulus | 3.953051e-11 |
GO:0007599 | hemostasis | 4.828410e-11 |
GO:0034728 | nucleosome organization | 6.770528e-11 |
GO:0003008 | system process | 8.650338e-11 |
GO:0050878 | regulation of body fluid levels | 9.761184e-11 |
GO:0000902 | cell morphogenesis | 1.119307e-10 |
GO:0030048 | actin filament-based movement | 1.208377e-10 |
GO:0048468 | cell development | 1.480479e-10 |
GO:0007596 | blood coagulation | 2.486993e-10 |
GO:0046314 | phosphocreatine biosynthetic process | 2.536907e-10 |
GO:0000904 | cell morphogenesis involved in differentiation | 2.599447e-10 |
GO:0050900 | leukocyte migration | 3.964504e-10 |
GO:0008544 | epidermis development | 5.570894e-10 |
GO:0006333 | chromatin assembly or disassembly | 7.012027e-10 |
GO:0006323 | DNA packaging | 1.058680e-9 |
GO:0006941 | striated muscle contraction | 1.167718e-9 |
GO:0000302 | response to reactive oxygen species | 1.452392e-9 |
GO:0007584 | response to nutrient | 1.690497e-9 |
GO:0071732 | cellular response to nitric oxide | 1.804424e-9 |
GO:0001894 | tissue homeostasis | 1.940467e-9 |
GO:0015889 | cobalamin transport | 1.965794e-9 |
GO:0002697 | regulation of immune effector process | 2.759308e-9 |
GO:0071103 | DNA conformation change | 3.343138e-9 |
GO:0072358 | cardiovascular system development | 3.393357e-9 |
GO:0010035 | response to inorganic substance | 3.511718e-9 |
GO:0006928 | cellular component movement | 5.584531e-9 |
GO:0030177 | positive regulation of Wnt receptor signaling pathway | 5.688573e-9 |
GO:0034621 | cellular macromolecular complex subunit organization | 7.004667e-9 |
GO:0051591 | response to cAMP | 7.022189e-9 |
GO:0055008 | cardiac muscle tissue morphogenesis | 1.009341e-8 |
GO:0006334 | nucleosome assembly | 1.471641e-8 |
GO:0032496 | response to lipopolysaccharide | 1.634506e-8 |
GO:0006461 | protein complex assembly | 2.174907e-8 |
GO:0001880 | Mullerian duct regression | 2.358011e-8 |
GO:0070271 | protein complex biogenesis | 2.538126e-8 |
GO:0060349 | bone morphogenesis | 2.673293e-8 |
GO:0030239 | myofibril assembly | 2.679425e-8 |
GO:0030241 | skeletal muscle myosin thick filament assembly | 3.196235e-8 |
GO:0007015 | actin filament organization | 3.196516e-8 |
GO:0034622 | cellular macromolecular complex assembly | 3.235189e-8 |
GO:0071822 | protein complex subunit organization | 3.429653e-8 |
GO:0006600 | creatine metabolic process | 3.568735e-8 |
GO:0050688 | regulation of defense response to virus | 5.523907e-8 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 5.967953e-8 |
GO:0042359 | vitamin D metabolic process | 6.479221e-8 |
GO:0006338 | chromatin remodeling | 7.901038e-8 |
GO:0031497 | chromatin assembly | 8.465838e-8 |
GO:0071731 | response to nitric oxide | 8.930594e-8 |
GO:0001546 | preantral ovarian follicle growth | 9.180654e-8 |
GO:0070252 | actin-mediated cell contraction | 9.537376e-8 |
GO:0030182 | neuron differentiation | 9.639221e-8 |
GO:0016032 | viral reproduction | 9.895055e-8 |
GO:0030049 | muscle filament sliding | 1.050176e-7 |
GO:0002237 | response to molecule of bacterial origin | 1.155143e-7 |
GO:0045214 | sarcomere organization | 1.158074e-7 |
GO:0048869 | cellular developmental process | 1.167596e-7 |
GO:0009611 | response to wounding | 1.188147e-7 |
GO:0071824 | protein-DNA complex subunit organization | 1.234563e-7 |
GO:0010717 | regulation of epithelial to mesenchymal transition | 1.334914e-7 |
GO:0048738 | cardiac muscle tissue development | 1.401302e-7 |
GO:0043933 | macromolecular complex subunit organization | 1.458167e-7 |
GO:0048644 | muscle organ morphogenesis | 1.557332e-7 |
GO:0031032 | actomyosin structure organization | 3.062055e-7 |
GO:0030154 | cell differentiation | 3.458298e-7 |
GO:0042221 | response to chemical stimulus | 3.656815e-7 |
GO:0007155 | cell adhesion | 3.734611e-7 |
GO:0008015 | blood circulation | 3.884433e-7 |
GO:0060415 | muscle tissue morphogenesis | 3.944731e-7 |
GO:0051259 | protein oligomerization | 3.946700e-7 |
GO:0060348 | bone development | 3.991388e-7 |
GO:2000491 | positive regulation of hepatic stellate cell activation | 4.149221e-7 |
GO:0009628 | response to abiotic stimulus | 4.412009e-7 |
GO:0060325 | face morphogenesis | 4.611516e-7 |
GO:0043900 | regulation of multi-organism process | 5.405775e-7 |
GO:0000910 | cytokinesis | 5.426929e-7 |
GO:0032502 | developmental process | 6.929957e-7 |
GO:0045010 | actin nucleation | 7.318109e-7 |
GO:0016192 | vesicle-mediated transport | 7.897352e-7 |
GO:0051014 | actin filament severing | 7.913082e-7 |
GO:0009235 | cobalamin metabolic process | 8.127002e-7 |
GO:0009653 | anatomical structure morphogenesis | 8.235287e-7 |
GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 8.462884e-7 |
GO:0007162 | negative regulation of cell adhesion | 8.999915e-7 |
GO:0002831 | regulation of response to biotic stimulus | 9.024402e-7 |
GO:0003013 | circulatory system process | 1.012928e-6 |
GO:0009617 | response to bacterium | 1.122694e-6 |
GO:0051234 | establishment of localization | 1.126946e-6 |
GO:0060323 | head morphogenesis | 1.140303e-6 |
GO:0007281 | germ cell development | 1.148325e-6 |
GO:0002576 | platelet degranulation | 1.335130e-6 |
GO:0042060 | wound healing | 1.357178e-6 |
GO:0071842 | cellular component organization at cellular level | 1.398248e-6 |
GO:0007266 | Rho protein signal transduction | 1.418640e-6 |
GO:0051179 | localization | 1.471797e-6 |
GO:0060033 | anatomical structure regression | 1.562788e-6 |
GO:0032501 | multicellular organismal process | 1.566188e-6 |
GO:0072678 | T cell migration | 1.617836e-6 |
GO:0010810 | regulation of cell-substrate adhesion | 1.780566e-6 |
GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway | 1.855544e-6 |
GO:0048747 | muscle fiber development | 1.917247e-6 |
GO:0031667 | response to nutrient levels | 2.019579e-6 |
GO:0065004 | protein-DNA complex assembly | 2.096483e-6 |
GO:0051716 | cellular response to stimulus | 2.320205e-6 |
GO:0070358 | actin polymerization-dependent cell motility | 2.425354e-6 |
GO:0060324 | face development | 2.440443e-6 |
GO:0014866 | skeletal myofibril assembly | 2.539614e-6 |
GO:0008064 | regulation of actin polymerization or depolymerization | 2.660962e-6 |
GO:0055002 | striated muscle cell development | 2.938176e-6 |
GO:0030029 | actin filament-based process | 3.018302e-6 |
GO:0006810 | transport | 3.024606e-6 |
GO:0071841 | cellular component organization or biogenesis at cellular level | 3.024943e-6 |
GO:0006936 | muscle contraction | 3.065011e-6 |
GO:0010171 | body morphogenesis | 3.269555e-6 |
GO:0048729 | tissue morphogenesis | 3.635137e-6 |
GO:0034109 | homotypic cell-cell adhesion | 3.650489e-6 |
GO:0002739 | regulation of cytokine secretion involved in immune response | 4.486499e-6 |
GO:0022008 | neurogenesis | 4.501803e-6 |
GO:0065003 | macromolecular complex assembly | 4.538079e-6 |
GO:0048856 | anatomical structure development | 4.588168e-6 |
GO:0071496 | cellular response to external stimulus | 5.162509e-6 |
GO:0001649 | osteoblast differentiation | 5.610586e-6 |
GO:0048871 | multicellular organismal homeostasis | 5.662337e-6 |
GO:0060426 | lung vasculature development | 5.815021e-6 |
GO:0060322 | head development | 6.415307e-6 |
GO:2000249 | regulation of actin cytoskeleton reorganization | 6.432211e-6 |
GO:0001944 | vasculature development | 7.757722e-6 |
GO:0051704 | multi-organism process | 7.962437e-6 |
GO:0006629 | lipid metabolic process | 8.070956e-6 |
GO:0055001 | muscle cell development | 8.334529e-6 |
GO:0051532 | regulation of NFAT protein import into nucleus | 9.734283e-6 |
GO:0043623 | cellular protein complex assembly | 9.751946e-6 |
GO:0007268 | synaptic transmission | 9.911084e-6 |
GO:0010506 | regulation of autophagy | 1.019272e-5 |
GO:0048699 | generation of neurons | 1.023999e-5 |
GO:0042542 | response to hydrogen peroxide | 1.025918e-5 |
GO:0002376 | immune system process | 1.034393e-5 |
GO:0017144 | drug metabolic process | 1.061978e-5 |
GO:0060828 | regulation of canonical Wnt receptor signaling pathway | 1.082018e-5 |
GO:0048545 | response to steroid hormone stimulus | 1.096767e-5 |
GO:0006026 | aminoglycan catabolic process | 1.135624e-5 |
GO:0048769 | sarcomerogenesis | 1.145993e-5 |
GO:0071460 | cellular response to cell-matrix adhesion | 1.217257e-5 |
GO:0030111 | regulation of Wnt receptor signaling pathway | 1.238444e-5 |
GO:0003214 | cardiac left ventricle morphogenesis | 1.271800e-5 |
GO:0034504 | protein localization to nucleus | 1.292314e-5 |
GO:0014002 | astrocyte development | 1.307290e-5 |
GO:0048613 | embryonic ectodermal digestive tract morphogenesis | 1.349869e-5 |
GO:0060461 | right lung morphogenesis | 1.349869e-5 |
GO:0090131 | mesenchyme migration | 1.349869e-5 |
GO:0060446 | branching involved in open tracheal system development | 1.349869e-5 |
GO:0002115 | store-operated calcium entry | 1.349869e-5 |
GO:0014822 | detection of wounding | 1.349869e-5 |
GO:0048371 | lateral mesodermal cell differentiation | 1.349869e-5 |
GO:2000279 | negative regulation of DNA biosynthetic process | 1.365294e-5 |
GO:0007605 | sensory perception of sound | 1.397329e-5 |
GO:0010927 | cellular component assembly involved in morphogenesis | 1.413680e-5 |
GO:0001568 | blood vessel development | 1.480797e-5 |
GO:0090288 | negative regulation of cellular response to growth factor stimulus | 1.487724e-5 |
GO:0003007 | heart morphogenesis | 1.624455e-5 |
GO:0016458 | gene silencing | 1.692820e-5 |
GO:0007154 | cell communication | 1.768529e-5 |
GO:0045198 | establishment of epithelial cell apical/basal polarity | 1.812510e-5 |
GO:0019254 | carnitine metabolic process, CoA-linked | 1.890374e-5 |
GO:0060048 | cardiac muscle contraction | 1.949212e-5 |
GO:0032274 | gonadotropin secretion | 1.949689e-5 |
GO:0002554 | serotonin secretion by platelet | 2.048245e-5 |
GO:0009991 | response to extracellular stimulus | 2.063495e-5 |
GO:0040029 | regulation of gene expression, epigenetic | 2.491937e-5 |
GO:0016477 | cell migration | 2.622504e-5 |
GO:0030335 | positive regulation of cell migration | 2.846668e-5 |
GO:0006887 | exocytosis | 3.053100e-5 |
GO:0016043 | cellular component organization | 3.119343e-5 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 3.123811e-5 |
GO:0060907 | positive regulation of macrophage cytokine production | 3.167728e-5 |
GO:0032800 | receptor biosynthetic process | 3.208276e-5 |
GO:0034337 | RNA folding | 3.212602e-5 |
GO:0071276 | cellular response to cadmium ion | 3.281190e-5 |
GO:0008211 | glucocorticoid metabolic process | 3.293271e-5 |
GO:0045920 | negative regulation of exocytosis | 3.344861e-5 |
GO:0006979 | response to oxidative stress | 3.422348e-5 |
GO:2000147 | positive regulation of cell motility | 3.536992e-5 |
GO:0015031 | protein transport | 3.885713e-5 |
GO:0051293 | establishment of spindle localization | 3.934864e-5 |
GO:0009887 | organ morphogenesis | 4.034531e-5 |
GO:0070489 | T cell aggregation | 4.217246e-5 |
GO:0003012 | muscle system process | 4.287038e-5 |
GO:0040017 | positive regulation of locomotion | 4.425089e-5 |
GO:0071840 | cellular component organization or biogenesis | 4.447200e-5 |
GO:0006700 | C21-steroid hormone biosynthetic process | 4.601110e-5 |
GO:0001501 | skeletal system development | 4.747917e-5 |
GO:0043301 | negative regulation of leukocyte degranulation | 4.828865e-5 |
GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway | 5.110472e-5 |
GO:0044130 | negative regulation of growth of symbiont in host | 5.129588e-5 |
GO:0048870 | cell motility | 5.238042e-5 |
GO:0016095 | polyprenol catabolic process | 5.564308e-5 |
GO:0030801 | positive regulation of cyclic nucleotide metabolic process | 5.948554e-5 |
GO:0048731 | system development | 6.037957e-5 |
GO:0070060 | 'de novo' actin filament nucleation | 6.041293e-5 |
GO:0016098 | monoterpenoid metabolic process | 6.068671e-5 |
GO:0007186 | G-protein coupled receptor protein signaling pathway | 6.096349e-5 |
GO:0030036 | actin cytoskeleton organization | 6.165977e-5 |
GO:0008104 | protein localization | 6.276372e-5 |
GO:0008217 | regulation of blood pressure | 6.353568e-5 |
GO:0045184 | establishment of protein localization | 6.378274e-5 |
GO:0002019 | regulation of renal output by angiotensin | 6.456021e-5 |
GO:0007522 | visceral muscle development | 6.843999e-5 |
GO:0090096 | positive regulation of metanephric cap mesenchymal cell proliferation | 7.024968e-5 |
GO:0050954 | sensory perception of mechanical stimulus | 7.469515e-5 |
GO:0051146 | striated muscle cell differentiation | 7.539982e-5 |
GO:0043903 | regulation of symbiosis, encompassing mutualism through parasitism | 7.556721e-5 |
GO:0010720 | positive regulation of cell development | 7.673617e-5 |
GO:0031648 | protein destabilization | 7.952549e-5 |
GO:0002699 | positive regulation of immune effector process | 8.041395e-5 |
GO:0048706 | embryonic skeletal system development | 8.062843e-5 |
GO:0071495 | cellular response to endogenous stimulus | 8.123092e-5 |
GO:0070848 | response to growth factor stimulus | 8.357693e-5 |
GO:0043555 | regulation of translation in response to stress | 8.548991e-5 |
GO:0060249 | anatomical structure homeostasis | 9.397445e-5 |
GO:0007020 | microtubule nucleation | 9.440951e-5 |
GO:0000086 | G2/M transition of mitotic cell cycle | 9.564590e-5 |
GO:0007275 | multicellular organismal development | 9.612360e-5 |
GO:0007166 | cell surface receptor linked signaling pathway | 9.846438e-5 |
GO:0042559 | pteridine-containing compound biosynthetic process | 1.038526e-4 |
GO:0043060 | meiotic metaphase I plate congression | 1.042924e-4 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 1.069046e-4 |
GO:0048609 | multicellular organismal reproductive process | 1.088240e-4 |
GO:0007283 | spermatogenesis | 1.101779e-4 |
GO:0000132 | establishment of mitotic spindle orientation | 1.137408e-4 |
GO:0055098 | response to low-density lipoprotein particle stimulus | 1.138247e-4 |
GO:0051641 | cellular localization | 1.138495e-4 |
GO:0034465 | response to carbon monoxide | 1.138919e-4 |
GO:0071363 | cellular response to growth factor stimulus | 1.157252e-4 |
GO:0002149 | hypochlorous acid biosynthetic process | 1.184591e-4 |
GO:0018283 | iron incorporation into metallo-sulfur cluster | 1.226027e-4 |
GO:0048841 | regulation of axon extension involved in axon guidance | 1.238415e-4 |
GO:0050715 | positive regulation of cytokine secretion | 1.257135e-4 |
GO:0031668 | cellular response to extracellular stimulus | 1.282577e-4 |
GO:0030832 | regulation of actin filament length | 1.288468e-4 |
GO:0051216 | cartilage development | 1.306732e-4 |
GO:0031669 | cellular response to nutrient levels | 1.316193e-4 |
GO:0030240 | skeletal muscle thin filament assembly | 1.319294e-4 |
GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway | 1.328999e-4 |
GO:0044283 | small molecule biosynthetic process | 1.334672e-4 |
GO:0060047 | heart contraction | 1.339780e-4 |
GO:0032411 | positive regulation of transporter activity | 1.393732e-4 |
GO:0010950 | positive regulation of endopeptidase activity | 1.442364e-4 |
GO:0044029 | hypomethylation of CpG island | 1.442364e-4 |
GO:0042699 | follicle-stimulating hormone signaling pathway | 1.442364e-4 |
GO:0085018 | maintenance of symbiont-containing vacuole via substance secreted by host | 1.462378e-4 |
GO:0035378 | carbon dioxide transmembrane transport | 1.462378e-4 |
GO:0030950 | establishment or maintenance of actin cytoskeleton polarity | 1.462378e-4 |
GO:0035377 | transepithelial water transport | 1.462378e-4 |
GO:0010625 | positive regulation of Schwann cell proliferation | 1.650874e-4 |
GO:0006897 | endocytosis | 1.733889e-4 |
GO:0030819 | positive regulation of cAMP biosynthetic process | 1.761999e-4 |
GO:0019226 | transmission of nerve impulse | 1.805093e-4 |
GO:0048382 | mesendoderm development | 1.819015e-4 |
GO:0050707 | regulation of cytokine secretion | 1.911582e-4 |
GO:0051272 | positive regulation of cellular component movement | 1.915605e-4 |
GO:0048370 | lateral mesoderm formation | 1.932419e-4 |
GO:0071404 | cellular response to low-density lipoprotein particle stimulus | 2.026109e-4 |
GO:0007253 | cytoplasmic sequestering of NF-kappaB | 2.026109e-4 |
GO:0030816 | positive regulation of cAMP metabolic process | 2.033890e-4 |
GO:0048368 | lateral mesoderm development | 2.040600e-4 |
GO:0055003 | cardiac myofibril assembly | 2.056910e-4 |
GO:0006950 | response to stress | 2.091093e-4 |
GO:0050862 | positive regulation of T cell receptor signaling pathway | 2.134493e-4 |
GO:0030952 | establishment or maintenance of cytoskeleton polarity | 2.146933e-4 |
GO:0006270 | DNA-dependent DNA replication initiation | 2.218776e-4 |
GO:0016226 | iron-sulfur cluster assembly | 2.221425e-4 |
GO:0048352 | paraxial mesoderm structural organization | 2.278776e-4 |
GO:0021998 | neural plate mediolateral regionalization | 2.278776e-4 |
GO:0006692 | prostanoid metabolic process | 2.331298e-4 |
GO:0044057 | regulation of system process | 2.350943e-4 |
GO:0003026 | regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback | 2.351132e-4 |
GO:0040001 | establishment of mitotic spindle localization | 2.386479e-4 |
GO:0014896 | muscle hypertrophy | 2.433050e-4 |
GO:0022403 | cell cycle phase | 2.527225e-4 |
GO:0006259 | DNA metabolic process | 2.553313e-4 |
GO:0007010 | cytoskeleton organization | 2.567856e-4 |
GO:0018879 | biphenyl metabolic process | 2.685934e-4 |
GO:0031330 | negative regulation of cellular catabolic process | 2.701665e-4 |
GO:0008207 | C21-steroid hormone metabolic process | 2.730202e-4 |
GO:0007128 | meiotic prophase I | 2.756615e-4 |
GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway | 2.756730e-4 |
GO:0018149 | peptide cross-linking | 2.867089e-4 |
GO:0007507 | heart development | 3.003825e-4 |
GO:0046626 | regulation of insulin receptor signaling pathway | 3.004200e-4 |
GO:0044419 | interspecies interaction between organisms | 3.166546e-4 |
GO:0006702 | androgen biosynthetic process | 3.424302e-4 |
GO:0019255 | glucose 1-phosphate metabolic process | 3.450120e-4 |
GO:0009988 | cell-cell recognition | 3.478767e-4 |
GO:0043534 | blood vessel endothelial cell migration | 3.608314e-4 |
GO:0048843 | negative regulation of axon extension involved in axon guidance | 3.697490e-4 |
GO:0071593 | lymphocyte aggregation | 3.739933e-4 |
GO:0030913 | paranodal junction assembly | 3.739933e-4 |
GO:0051384 | response to glucocorticoid stimulus | 3.748413e-4 |
GO:0001919 | regulation of receptor recycling | 3.770920e-4 |
GO:0001503 | ossification | 3.791258e-4 |
GO:0000272 | polysaccharide catabolic process | 4.059874e-4 |
GO:0071402 | cellular response to lipoprotein particle stimulus | 4.113277e-4 |
GO:0030224 | monocyte differentiation | 4.166118e-4 |
GO:0048610 | cellular process involved in reproduction | 4.203100e-4 |
GO:0060291 | long-term synaptic potentiation | 4.232485e-4 |
GO:0045355 | negative regulation of interferon-alpha biosynthetic process | 4.242104e-4 |
GO:0034314 | Arp2/3 complex-mediated actin nucleation | 4.286896e-4 |
GO:0051580 | regulation of neurotransmitter uptake | 4.313413e-4 |
GO:0009607 | response to biotic stimulus | 4.397899e-4 |
GO:0050886 | endocrine process | 4.399370e-4 |
GO:0048708 | astrocyte differentiation | 4.582381e-4 |
GO:0071222 | cellular response to lipopolysaccharide | 4.641518e-4 |
GO:0042407 | cristae formation | 4.707719e-4 |
GO:0043438 | acetoacetic acid metabolic process | 4.878718e-4 |
GO:0007165 | signal transduction | 5.100117e-4 |
GO:0051324 | prophase | 5.394550e-4 |
GO:0032049 | cardiolipin biosynthetic process | 5.452737e-4 |
GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity | 5.570838e-4 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 5.570838e-4 |
GO:0008594 | photoreceptor cell morphogenesis | 5.599897e-4 |
GO:0010935 | regulation of macrophage cytokine production | 5.603981e-4 |
GO:0046903 | secretion | 5.682684e-4 |
GO:0051534 | negative regulation of NFAT protein import into nucleus | 5.735867e-4 |
GO:0070098 | chemokine-mediated signaling pathway | 5.936659e-4 |
GO:0044255 | cellular lipid metabolic process | 5.942901e-4 |
GO:0042446 | hormone biosynthetic process | 6.128818e-4 |
GO:0032374 | regulation of cholesterol transport | 6.222737e-4 |
GO:0006690 | icosanoid metabolic process | 6.256496e-4 |
GO:0035036 | sperm-egg recognition | 6.304297e-4 |
GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response | 6.332942e-4 |
GO:0003408 | optic cup formation involved in camera-type eye development | 6.496630e-4 |
GO:0032069 | regulation of nuclease activity | 6.544276e-4 |
GO:0055093 | response to hyperoxia | 6.706469e-4 |
GO:0021589 | cerebellum structural organization | 6.987491e-4 |
GO:0060904 | regulation of protein folding in endoplasmic reticulum | 6.987491e-4 |
GO:0009822 | alkaloid catabolic process | 6.987491e-4 |
GO:0042994 | cytoplasmic sequestering of transcription factor | 7.032770e-4 |
GO:0051707 | response to other organism | 7.051663e-4 |
GO:0001516 | prostaglandin biosynthetic process | 7.419513e-4 |
GO:0007007 | inner mitochondrial membrane organization | 7.744097e-4 |
GO:0007229 | integrin-mediated signaling pathway | 7.745517e-4 |
GO:0040012 | regulation of locomotion | 7.765727e-4 |
GO:0033559 | unsaturated fatty acid metabolic process | 7.805622e-4 |
GO:0001956 | positive regulation of neurotransmitter secretion | 7.954398e-4 |
GO:0017156 | calcium ion-dependent exocytosis | 8.023358e-4 |
GO:0042692 | muscle cell differentiation | 8.375559e-4 |
GO:0003084 | positive regulation of systemic arterial blood pressure | 8.450301e-4 |
GO:0008202 | steroid metabolic process | 8.460776e-4 |
GO:0035684 | helper T cell extravasation | 8.595136e-4 |
GO:0003108 | negative regulation of the force of heart contraction by chemical signal | 8.595136e-4 |
GO:0071257 | cellular response to electrical stimulus | 8.634353e-4 |
GO:0000216 | M/G1 transition of mitotic cell cycle | 8.648573e-4 |
GO:0042758 | long-chain fatty acid catabolic process | 8.689428e-4 |
GO:0042413 | carnitine catabolic process | 8.689428e-4 |
GO:0046724 | oxalic acid secretion | 8.689428e-4 |
GO:0035994 | response to muscle stretch | 8.689428e-4 |
GO:0019265 | glycine biosynthetic process, by transamination of glyoxylate | 8.689428e-4 |
GO:0051270 | regulation of cellular component movement | 8.711983e-4 |
GO:0006693 | prostaglandin metabolic process | 9.050196e-4 |
GO:0060067 | cervix development | 9.296146e-4 |
GO:0042992 | negative regulation of transcription factor import into nucleus | 9.314322e-4 |
GO:0071157 | negative regulation of cell cycle arrest | 9.534189e-4 |
GO:0003015 | heart process | 9.677053e-4 |
GO:0045039 | protein import into mitochondrial inner membrane | 9.740183e-4 |
GO:0018206 | peptidyl-methionine modification | 9.973384e-4 |
GO:0002418 | immune response to tumor cell | 1.000160e-3 |
GO:0007223 | Wnt receptor signaling pathway, calcium modulating pathway | 1.018661e-3 |
GO:0023052 | signaling | 1.020911e-3 |
GO:0032940 | secretion by cell | 1.027749e-3 |
GO:0032236 | positive regulation of calcium ion transport via store-operated calcium channel activity | 1.042261e-3 |
GO:0003300 | cardiac muscle hypertrophy | 1.044069e-3 |
GO:0071219 | cellular response to molecule of bacterial origin | 1.050212e-3 |
GO:0009309 | amine biosynthetic process | 1.075067e-3 |
GO:0002904 | positive regulation of B cell apoptosis | 1.079315e-3 |
GO:0050877 | neurological system process | 1.089481e-3 |
GO:0002026 | regulation of the force of heart contraction | 1.091098e-3 |
GO:0051590 | positive regulation of neurotransmitter transport | 1.097248e-3 |
GO:0033013 | tetrapyrrole metabolic process | 1.098715e-3 |
GO:0030155 | regulation of cell adhesion | 1.107245e-3 |
GO:0032897 | negative regulation of viral transcription | 1.116253e-3 |
GO:0070230 | positive regulation of lymphocyte apoptosis | 1.124852e-3 |
GO:0009888 | tissue development | 1.163361e-3 |
GO:0006032 | chitin catabolic process | 1.171206e-3 |
GO:0030836 | positive regulation of actin filament depolymerization | 1.171206e-3 |
GO:0071385 | cellular response to glucocorticoid stimulus | 1.191234e-3 |
GO:0002158 | osteoclast proliferation | 1.194042e-3 |
GO:0043901 | negative regulation of multi-organism process | 1.199844e-3 |
GO:0045981 | positive regulation of nucleotide metabolic process | 1.204259e-3 |
GO:0055069 | zinc ion homeostasis | 1.219254e-3 |
GO:0048286 | lung alveolus development | 1.221411e-3 |
GO:0046456 | icosanoid biosynthetic process | 1.224954e-3 |
GO:0042445 | hormone metabolic process | 1.240078e-3 |
GO:0051414 | response to cortisol stimulus | 1.241703e-3 |
GO:0000305 | response to oxygen radical | 1.249268e-3 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 1.251093e-3 |
GO:0019695 | choline metabolic process | 1.285547e-3 |
GO:0042737 | drug catabolic process | 1.286409e-3 |
GO:0035089 | establishment of apical/basal cell polarity | 1.286409e-3 |
GO:0071346 | cellular response to interferon-gamma | 1.297806e-3 |
GO:0010897 | negative regulation of triglyceride catabolic process | 1.316061e-3 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 1.316061e-3 |
GO:0007000 | nucleolus organization | 1.327651e-3 |
GO:0006066 | alcohol metabolic process | 1.332173e-3 |
GO:0002720 | positive regulation of cytokine production involved in immune response | 1.338918e-3 |
GO:0006777 | Mo-molybdopterin cofactor biosynthetic process | 1.360952e-3 |
GO:0061350 | planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | 1.378568e-3 |
GO:0061354 | planar cell polarity pathway involved in pericardium morphogenesis | 1.378568e-3 |
GO:0061349 | planar cell polarity pathway involved in cardiac right atrium morphogenesis | 1.378568e-3 |
GO:0060210 | metestrus | 1.378568e-3 |
GO:0061347 | planar cell polarity pathway involved in outflow tract morphogenesis | 1.378568e-3 |
GO:0061348 | planar cell polarity pathway involved in ventricular septum morphogenesis | 1.378568e-3 |
GO:0060463 | lung lobe morphogenesis | 1.381642e-3 |
GO:0055013 | cardiac muscle cell development | 1.387534e-3 |
GO:0015866 | ADP transport | 1.388306e-3 |
GO:0050714 | positive regulation of protein secretion | 1.405275e-3 |
GO:0007506 | gonadal mesoderm development | 1.420438e-3 |
GO:0048143 | astrocyte activation | 1.440186e-3 |
GO:0002718 | regulation of cytokine production involved in immune response | 1.449076e-3 |
GO:0070483 | detection of hypoxia | 1.449880e-3 |
GO:0030804 | positive regulation of cyclic nucleotide biosynthetic process | 1.497094e-3 |
GO:0032414 | positive regulation of ion transmembrane transporter activity | 1.524701e-3 |
GO:0014895 | smooth muscle hypertrophy | 1.535008e-3 |
GO:0003106 | negative regulation of glomerular filtration by angiotensin | 1.535008e-3 |
GO:0051045 | negative regulation of membrane protein ectodomain proteolysis | 1.546805e-3 |
GO:2000145 | regulation of cell motility | 1.563988e-3 |
GO:0006636 | unsaturated fatty acid biosynthetic process | 1.566626e-3 |
GO:0050433 | regulation of catecholamine secretion | 1.581148e-3 |
GO:0006766 | vitamin metabolic process | 1.582896e-3 |
GO:0000422 | mitochondrion degradation | 1.599655e-3 |
GO:0002682 | regulation of immune system process | 1.628978e-3 |
GO:0001738 | morphogenesis of a polarized epithelium | 1.629439e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0071230 | cellular response to amino acid stimulus | 1.491973e-31 |
GO:0071229 | cellular response to acid | 1.516784e-30 |
GO:0001957 | intramembranous ossification | 7.636047e-28 |
GO:0071417 | cellular response to organic nitrogen | 1.963237e-26 |
GO:0071418 | cellular response to amine stimulus | 2.244784e-26 |
GO:0060346 | bone trabecula formation | 5.676300e-25 |
GO:0032964 | collagen biosynthetic process | 3.347204e-22 |
GO:0043200 | response to amino acid stimulus | 1.965798e-20 |
GO:0010718 | positive regulation of epithelial to mesenchymal transition | 4.104005e-20 |
GO:0030199 | collagen fibril organization | 3.083025e-19 |
GO:0010770 | positive regulation of cell morphogenesis involved in differentiation | 1.441791e-18 |
GO:0010717 | regulation of epithelial to mesenchymal transition | 2.426359e-18 |
GO:0034505 | tooth mineralization | 4.131477e-18 |
GO:0070208 | protein heterotrimerization | 5.671475e-18 |
GO:0001101 | response to acid | 1.491439e-17 |
GO:0043589 | skin morphogenesis | 3.883809e-17 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 6.513913e-17 |
GO:0060343 | trabecula formation | 8.159252e-17 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 9.381522e-17 |
GO:0010897 | negative regulation of triglyceride catabolic process | 9.381522e-17 |
GO:0002739 | regulation of cytokine secretion involved in immune response | 3.904312e-15 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 5.255166e-15 |
GO:0070508 | cholesterol import | 6.759232e-15 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 1.300614e-14 |
GO:0050713 | negative regulation of interleukin-1 beta secretion | 1.347387e-14 |
GO:0061383 | trabecula morphogenesis | 2.944652e-14 |
GO:0014075 | response to amine stimulus | 3.970514e-14 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 4.167679e-14 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 8.307336e-14 |
GO:0070206 | protein trimerization | 8.913210e-14 |
GO:0034382 | chylomicron remnant clearance | 1.461879e-13 |
GO:0050711 | negative regulation of interleukin-1 secretion | 4.877942e-13 |
GO:0032963 | collagen metabolic process | 6.442147e-13 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 7.816697e-13 |
GO:0010984 | regulation of lipoprotein particle clearance | 9.380188e-13 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 1.031430e-12 |
GO:0060621 | negative regulation of cholesterol import | 1.374374e-12 |
GO:0071260 | cellular response to mechanical stimulus | 3.086195e-12 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 4.805448e-12 |
GO:0048730 | epidermis morphogenesis | 6.855920e-12 |
GO:0060620 | regulation of cholesterol import | 7.411625e-12 |
GO:0001935 | endothelial cell proliferation | 9.063496e-12 |
GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling | 9.213705e-12 |
GO:0044236 | multicellular organismal metabolic process | 1.182318e-11 |
GO:0001649 | osteoblast differentiation | 1.193292e-11 |
GO:0090263 | positive regulation of canonical Wnt receptor signaling pathway | 1.860703e-11 |
GO:0034377 | plasma lipoprotein particle assembly | 2.553390e-11 |
GO:0030198 | extracellular matrix organization | 2.654574e-11 |
GO:0032488 | Cdc42 protein signal transduction | 3.351256e-11 |
GO:0050710 | negative regulation of cytokine secretion | 4.718093e-11 |
GO:0006695 | cholesterol biosynthetic process | 9.001003e-11 |
GO:0001958 | endochondral ossification | 1.402013e-10 |
GO:0050995 | negative regulation of lipid catabolic process | 2.824805e-10 |
GO:0048261 | negative regulation of receptor-mediated endocytosis | 3.289960e-10 |
GO:0032375 | negative regulation of cholesterol transport | 3.335872e-10 |
GO:0010873 | positive regulation of cholesterol esterification | 6.053723e-10 |
GO:0043588 | skin development | 7.698601e-10 |
GO:0060192 | negative regulation of lipase activity | 7.699662e-10 |
GO:0016126 | sterol biosynthetic process | 7.982829e-10 |
GO:0032800 | receptor biosynthetic process | 1.000717e-9 |
GO:0010243 | response to organic nitrogen | 1.519847e-9 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 1.798832e-9 |
GO:0060325 | face morphogenesis | 4.955592e-9 |
GO:2000054 | negative regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 5.176150e-9 |
GO:0010872 | regulation of cholesterol esterification | 6.968982e-9 |
GO:0034380 | high-density lipoprotein particle assembly | 7.622115e-9 |
GO:0032691 | negative regulation of interleukin-1 beta production | 8.679010e-9 |
GO:0060323 | head morphogenesis | 1.051539e-8 |
GO:0045212 | neurotransmitter receptor biosynthetic process | 1.174927e-8 |
GO:0032930 | positive regulation of superoxide anion generation | 1.174927e-8 |
GO:0065005 | protein-lipid complex assembly | 1.224728e-8 |
GO:0060349 | bone morphogenesis | 1.298657e-8 |
GO:0031214 | biomineral tissue development | 1.344108e-8 |
GO:0050709 | negative regulation of protein secretion | 1.394184e-8 |
GO:0007584 | response to nutrient | 1.420825e-8 |
GO:0071295 | cellular response to vitamin | 1.444514e-8 |
GO:0048259 | regulation of receptor-mediated endocytosis | 1.595800e-8 |
GO:0060350 | endochondral bone morphogenesis | 1.612793e-8 |
GO:0010812 | negative regulation of cell-substrate adhesion | 1.691332e-8 |
GO:0034375 | high-density lipoprotein particle remodeling | 2.078320e-8 |
GO:0090209 | negative regulation of triglyceride metabolic process | 2.126084e-8 |
GO:0045806 | negative regulation of endocytosis | 2.266321e-8 |
GO:0032651 | regulation of interleukin-1 beta production | 2.319792e-8 |
GO:0032692 | negative regulation of interleukin-1 production | 2.750532e-8 |
GO:0008542 | visual learning | 3.462392e-8 |
GO:0006642 | triglyceride mobilization | 3.621376e-8 |
GO:0071356 | cellular response to tumor necrosis factor | 3.713626e-8 |
GO:0032928 | regulation of superoxide anion generation | 3.954228e-8 |
GO:0030177 | positive regulation of Wnt receptor signaling pathway | 3.955918e-8 |
GO:2000053 | regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 5.798007e-8 |
GO:0034612 | response to tumor necrosis factor | 5.858904e-8 |
GO:0032652 | regulation of interleukin-1 production | 7.045845e-8 |
GO:0045922 | negative regulation of fatty acid metabolic process | 7.048149e-8 |
GO:0007162 | negative regulation of cell adhesion | 8.401327e-8 |
GO:0006694 | steroid biosynthetic process | 1.063230e-7 |
GO:0019915 | lipid storage | 1.089836e-7 |
GO:0033273 | response to vitamin | 1.261375e-7 |
GO:0016191 | synaptic vesicle uncoating | 1.357801e-7 |
GO:0071300 | cellular response to retinoic acid | 1.745095e-7 |
GO:0071299 | cellular response to vitamin A | 2.473509e-7 |
GO:0001503 | ossification | 2.655921e-7 |
GO:0030261 | chromosome condensation | 2.720235e-7 |
GO:0071214 | cellular response to abiotic stimulus | 2.880311e-7 |
GO:0031670 | cellular response to nutrient | 3.257228e-7 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 3.352788e-7 |
GO:0060828 | regulation of canonical Wnt receptor signaling pathway | 3.576426e-7 |
GO:0032682 | negative regulation of chemokine production | 5.223650e-7 |
GO:0060693 | regulation of branching involved in salivary gland morphogenesis | 5.249347e-7 |
GO:2000256 | positive regulation of male germ cell proliferation | 5.527741e-7 |
GO:0042231 | interleukin-13 biosynthetic process | 5.527741e-7 |
GO:0001579 | medium-chain fatty acid transport | 5.527741e-7 |
GO:0033189 | response to vitamin A | 5.529950e-7 |
GO:0034381 | plasma lipoprotein particle clearance | 5.641401e-7 |
GO:0090322 | regulation of superoxide metabolic process | 5.673364e-7 |
GO:0043534 | blood vessel endothelial cell migration | 6.134739e-7 |
GO:0060191 | regulation of lipase activity | 6.639730e-7 |
GO:0032526 | response to retinoic acid | 6.889372e-7 |
GO:0046069 | cGMP catabolic process | 7.864468e-7 |
GO:0045940 | positive regulation of steroid metabolic process | 8.118339e-7 |
GO:0033700 | phospholipid efflux | 8.526158e-7 |
GO:0003012 | muscle system process | 9.113759e-7 |
GO:0002642 | positive regulation of immunoglobulin biosynthetic process | 9.523023e-7 |
GO:0010896 | regulation of triglyceride catabolic process | 9.934622e-7 |
GO:0010951 | negative regulation of endopeptidase activity | 1.149321e-6 |
GO:0007338 | single fertilization | 1.275391e-6 |
GO:0010171 | body morphogenesis | 1.727713e-6 |
GO:0030300 | regulation of intestinal cholesterol absorption | 2.195312e-6 |
GO:0070328 | triglyceride homeostasis | 2.420301e-6 |
GO:0051291 | protein heterooligomerization | 2.446966e-6 |
GO:0001887 | selenium compound metabolic process | 2.663495e-6 |
GO:0007632 | visual behavior | 2.665050e-6 |
GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus | 2.993083e-6 |
GO:0010720 | positive regulation of cell development | 3.215771e-6 |
GO:0071495 | cellular response to endogenous stimulus | 3.623699e-6 |
GO:0050673 | epithelial cell proliferation | 3.721991e-6 |
GO:0061028 | establishment of endothelial barrier | 3.857990e-6 |
GO:0006629 | lipid metabolic process | 4.028152e-6 |
GO:0032374 | regulation of cholesterol transport | 4.311301e-6 |
GO:0060324 | face development | 4.393849e-6 |
GO:0060348 | bone development | 4.514614e-6 |
GO:0071827 | plasma lipoprotein particle organization | 4.729760e-6 |
GO:0034104 | negative regulation of tissue remodeling | 4.925410e-6 |
GO:0046068 | cGMP metabolic process | 5.021213e-6 |
GO:0006641 | triglyceride metabolic process | 5.163821e-6 |
GO:0030111 | regulation of Wnt receptor signaling pathway | 5.306755e-6 |
GO:0050706 | regulation of interleukin-1 beta secretion | 5.435508e-6 |
GO:0048705 | skeletal system morphogenesis | 5.707002e-6 |
GO:0006639 | acylglycerol metabolic process | 6.032847e-6 |
GO:0051224 | negative regulation of protein transport | 6.149833e-6 |
GO:0090207 | regulation of triglyceride metabolic process | 6.199658e-6 |
GO:0043691 | reverse cholesterol transport | 7.186501e-6 |
GO:0061302 | smooth muscle cell-matrix adhesion | 7.941690e-6 |
GO:2000270 | negative regulation of fibroblast apoptosis | 8.554767e-6 |
GO:2000271 | positive regulation of fibroblast apoptosis | 8.554767e-6 |
GO:2000080 | negative regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation | 8.554767e-6 |
GO:0044345 | stromal-epithelial cell signaling involved in prostate gland development | 8.554767e-6 |
GO:0008211 | glucocorticoid metabolic process | 8.708391e-6 |
GO:0032369 | negative regulation of lipid transport | 8.715456e-6 |
GO:0050707 | regulation of cytokine secretion | 9.458011e-6 |
GO:0006638 | neutral lipid metabolic process | 9.952321e-6 |
GO:0050994 | regulation of lipid catabolic process | 1.127669e-5 |
GO:0045085 | negative regulation of interleukin-2 biosynthetic process | 1.197107e-5 |
GO:0046486 | glycerolipid metabolic process | 1.210196e-5 |
GO:0050704 | regulation of interleukin-1 secretion | 1.290193e-5 |
GO:2000079 | regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation | 1.387649e-5 |
GO:0071380 | cellular response to prostaglandin E stimulus | 1.387649e-5 |
GO:0042095 | interferon-gamma biosynthetic process | 1.387649e-5 |
GO:0006936 | muscle contraction | 1.426178e-5 |
GO:0010817 | regulation of hormone levels | 1.496890e-5 |
GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport | 1.516858e-5 |
GO:0006710 | androgen catabolic process | 1.516858e-5 |
GO:0022603 | regulation of anatomical structure morphogenesis | 1.858260e-5 |
GO:0044255 | cellular lipid metabolic process | 1.895543e-5 |
GO:0008203 | cholesterol metabolic process | 1.907974e-5 |
GO:0044058 | regulation of digestive system process | 1.945462e-5 |
GO:0033344 | cholesterol efflux | 2.050004e-5 |
GO:0051382 | kinetochore assembly | 2.166703e-5 |
GO:0046464 | acylglycerol catabolic process | 2.292200e-5 |
GO:0006939 | smooth muscle contraction | 2.504479e-5 |
GO:0006927 | transformed cell apoptosis | 2.620417e-5 |
GO:0051142 | positive regulation of NK T cell proliferation | 2.690377e-5 |
GO:0016042 | lipid catabolic process | 2.717408e-5 |
GO:0016125 | sterol metabolic process | 2.840318e-5 |
GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 2.911779e-5 |
GO:0007266 | Rho protein signal transduction | 3.020124e-5 |
GO:0051004 | regulation of lipoprotein lipase activity | 3.112598e-5 |
GO:0019433 | triglyceride catabolic process | 3.620551e-5 |
GO:0051533 | positive regulation of NFAT protein import into nucleus | 3.845084e-5 |
GO:0043117 | positive regulation of vascular permeability | 3.845084e-5 |
GO:0042304 | regulation of fatty acid biosynthetic process | 3.852842e-5 |
GO:0071363 | cellular response to growth factor stimulus | 3.929431e-5 |
GO:0001944 | vasculature development | 3.952446e-5 |
GO:0061181 | regulation of chondrocyte development | 3.986879e-5 |
GO:0097006 | regulation of plasma lipoprotein particle levels | 4.006845e-5 |
GO:0033689 | negative regulation of osteoblast proliferation | 4.264778e-5 |
GO:0008610 | lipid biosynthetic process | 4.464800e-5 |
GO:0002718 | regulation of cytokine production involved in immune response | 4.561323e-5 |
GO:0045994 | positive regulation of translational initiation by iron | 4.806071e-5 |
GO:0061048 | negative regulation of branching involved in lung morphogenesis | 4.806071e-5 |
GO:0034116 | positive regulation of heterotypic cell-cell adhesion | 4.806071e-5 |
GO:0002037 | negative regulation of L-glutamate transport | 4.806071e-5 |
GO:0042158 | lipoprotein biosynthetic process | 4.918100e-5 |
GO:0070305 | response to cGMP | 4.984313e-5 |
GO:0043542 | endothelial cell migration | 6.035844e-5 |
GO:0008202 | steroid metabolic process | 6.078680e-5 |
GO:0045076 | regulation of interleukin-2 biosynthetic process | 6.230287e-5 |
GO:0008544 | epidermis development | 6.975954e-5 |
GO:0051346 | negative regulation of hydrolase activity | 6.994461e-5 |
GO:0033143 | regulation of steroid hormone receptor signaling pathway | 7.072181e-5 |
GO:0048565 | digestive tract development | 7.473891e-5 |
GO:0060322 | head development | 7.564621e-5 |
GO:0017156 | calcium ion-dependent exocytosis | 7.666975e-5 |
GO:0002318 | myeloid progenitor cell differentiation | 7.926154e-5 |
GO:0032757 | positive regulation of interleukin-8 production | 8.514814e-5 |
GO:0046641 | positive regulation of alpha-beta T cell proliferation | 8.606640e-5 |
GO:0042445 | hormone metabolic process | 8.793862e-5 |
GO:0030100 | regulation of endocytosis | 9.135302e-5 |
GO:0034103 | regulation of tissue remodeling | 9.410745e-5 |
GO:2000275 | regulation of oxidative phosphorylation uncoupler activity | 9.501119e-5 |
GO:0060627 | regulation of vesicle-mediated transport | 9.567340e-5 |
GO:0051383 | kinetochore organization | 9.629758e-5 |
GO:0009992 | cellular water homeostasis | 9.629758e-5 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 9.629758e-5 |
GO:0051261 | protein depolymerization | 9.715799e-5 |
GO:0030325 | adrenal gland development | 1.082908e-4 |
GO:0007202 | activation of phospholipase C activity | 1.089634e-4 |
GO:0033146 | regulation of estrogen receptor signaling pathway | 1.132576e-4 |
GO:0014819 | regulation of skeletal muscle contraction | 1.132576e-4 |
GO:0071321 | cellular response to cGMP | 1.235697e-4 |
GO:0006581 | acetylcholine catabolic process | 1.235697e-4 |
GO:0014034 | neural crest cell fate commitment | 1.278908e-4 |
GO:0031647 | regulation of protein stability | 1.305748e-4 |
GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity | 1.321148e-4 |
GO:0034695 | response to prostaglandin E stimulus | 1.417019e-4 |
GO:0008625 | induction of apoptosis via death domain receptors | 1.426192e-4 |
GO:0018904 | organic ether metabolic process | 1.430966e-4 |
GO:0015914 | phospholipid transport | 1.521904e-4 |
GO:0010939 | regulation of necrotic cell death | 1.533324e-4 |
GO:0007166 | cell surface receptor linked signaling pathway | 1.563524e-4 |
GO:0034369 | plasma lipoprotein particle remodeling | 1.569251e-4 |
GO:0002115 | store-operated calcium entry | 1.588545e-4 |
GO:0002921 | negative regulation of humoral immune response | 1.610938e-4 |
GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production | 1.615036e-4 |
GO:0003008 | system process | 1.648622e-4 |
GO:0050821 | protein stabilization | 1.691278e-4 |
GO:0006662 | glycerol ether metabolic process | 1.700224e-4 |
GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus | 1.780163e-4 |
GO:0032642 | regulation of chemokine production | 1.781092e-4 |
GO:0071504 | cellular response to heparin | 1.845312e-4 |
GO:0031667 | response to nutrient levels | 1.848842e-4 |
GO:0006650 | glycerophospholipid metabolic process | 1.886834e-4 |
GO:0071845 | cellular component disassembly at cellular level | 1.895887e-4 |
GO:0009214 | cyclic nucleotide catabolic process | 1.941298e-4 |
GO:0042439 | ethanolamine-containing compound metabolic process | 2.031916e-4 |
GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation | 2.097625e-4 |
GO:0022604 | regulation of cell morphogenesis | 2.181007e-4 |
GO:0030449 | regulation of complement activation | 2.209837e-4 |
GO:0055123 | digestive system development | 2.226411e-4 |
GO:0001885 | endothelial cell development | 2.247290e-4 |
GO:0032368 | regulation of lipid transport | 2.271532e-4 |
GO:0046503 | glycerolipid catabolic process | 2.285392e-4 |
GO:0051901 | positive regulation of mitochondrial depolarization | 2.347344e-4 |
GO:0060555 | induction of necroptosis by extracellular signals | 2.381400e-4 |
GO:0008306 | associative learning | 2.386180e-4 |
GO:0022411 | cellular component disassembly | 2.417154e-4 |
GO:0034623 | cellular macromolecular complex disassembly | 2.425381e-4 |
GO:0006198 | cAMP catabolic process | 2.425381e-4 |
GO:0045214 | sarcomere organization | 2.427467e-4 |
GO:0045213 | neurotransmitter receptor metabolic process | 2.435194e-4 |
GO:0035414 | negative regulation of catenin import into nucleus | 2.456726e-4 |
GO:0071503 | response to heparin | 2.459874e-4 |
GO:0045834 | positive regulation of lipid metabolic process | 2.522705e-4 |
GO:0001963 | synaptic transmission, dopaminergic | 2.721690e-4 |
GO:0003084 | positive regulation of systemic arterial blood pressure | 2.721690e-4 |
GO:0014874 | response to stimulus involved in regulation of muscle adaptation | 2.738110e-4 |
GO:0010769 | regulation of cell morphogenesis involved in differentiation | 2.824109e-4 |
GO:0010543 | regulation of platelet activation | 2.942934e-4 |
GO:0007440 | foregut morphogenesis | 3.120420e-4 |
GO:0010863 | positive regulation of phospholipase C activity | 3.134357e-4 |
GO:0060688 | regulation of morphogenesis of a branching structure | 3.235937e-4 |
GO:0002861 | regulation of inflammatory response to antigenic stimulus | 3.273559e-4 |
GO:0001568 | blood vessel development | 3.307383e-4 |
GO:0046470 | phosphatidylcholine metabolic process | 3.384336e-4 |
GO:0072358 | cardiovascular system development | 3.400621e-4 |
GO:0043462 | regulation of ATPase activity | 3.438729e-4 |
GO:0045916 | negative regulation of complement activation | 3.484199e-4 |
GO:0035412 | regulation of catenin import into nucleus | 3.623720e-4 |
GO:0048706 | embryonic skeletal system development | 3.632102e-4 |
GO:0002678 | positive regulation of chronic inflammatory response | 3.685551e-4 |
GO:0043438 | acetoacetic acid metabolic process | 3.691525e-4 |
GO:0042632 | cholesterol homeostasis | 3.756535e-4 |
GO:0032984 | macromolecular complex disassembly | 3.779154e-4 |
GO:0008291 | acetylcholine metabolic process | 3.923673e-4 |
GO:0015760 | glucose-6-phosphate transport | 3.923673e-4 |
GO:0072240 | metanephric DCT cell differentiation | 3.972187e-4 |
GO:2000117 | negative regulation of cysteine-type endopeptidase activity | 3.972187e-4 |
GO:0072227 | metanephric macula densa development | 3.972187e-4 |
GO:0002036 | regulation of L-glutamate transport | 3.972187e-4 |
GO:0032423 | regulation of mismatch repair | 4.038076e-4 |
GO:0014029 | neural crest formation | 4.038076e-4 |
GO:0010876 | lipid localization | 4.094606e-4 |
GO:0008624 | induction of apoptosis by extracellular signals | 4.170969e-4 |
GO:0090244 | Wnt receptor signaling pathway involved in somitogenesis | 4.176197e-4 |
GO:0071316 | cellular response to nicotine | 4.176197e-4 |
GO:0007186 | G-protein coupled receptor protein signaling pathway | 4.347998e-4 |
GO:0046640 | regulation of alpha-beta T cell proliferation | 4.570050e-4 |
GO:0044341 | sodium-dependent phosphate transport | 4.723149e-4 |
GO:0000185 | activation of MAPKKK activity | 4.977351e-4 |
GO:0001818 | negative regulation of cytokine production | 5.039710e-4 |
GO:0072520 | seminiferous tubule development | 5.055784e-4 |
GO:0060557 | positive regulation of vitamin D biosynthetic process | 5.055784e-4 |
GO:0002019 | regulation of renal output by angiotensin | 5.055784e-4 |
GO:0032103 | positive regulation of response to external stimulus | 5.221463e-4 |
GO:0002920 | regulation of humoral immune response | 5.451067e-4 |
GO:0043137 | DNA replication, removal of RNA primer | 5.492555e-4 |
GO:0032971 | regulation of muscle filament sliding | 5.492555e-4 |
GO:0051048 | negative regulation of secretion | 5.690079e-4 |
GO:0009950 | dorsal/ventral axis specification | 5.818367e-4 |
GO:0060312 | regulation of blood vessel remodeling | 5.857623e-4 |
GO:0001869 | negative regulation of complement activation, lectin pathway | 5.898902e-4 |
GO:0072530 | purine-containing compound transmembrane transport | 6.154679e-4 |
GO:0042058 | regulation of epidermal growth factor receptor signaling pathway | 6.331164e-4 |
GO:0031448 | positive regulation of fast-twitch skeletal muscle fiber contraction | 6.416753e-4 |
GO:0010518 | positive regulation of phospholipase activity | 6.891665e-4 |
GO:0009991 | response to extracellular stimulus | 6.895086e-4 |
GO:0010155 | regulation of proton transport | 6.942462e-4 |
GO:0034379 | very-low-density lipoprotein particle assembly | 6.958654e-4 |
GO:0002697 | regulation of immune effector process | 6.963351e-4 |
GO:0050727 | regulation of inflammatory response | 7.005999e-4 |
GO:0070602 | regulation of centromeric sister chromatid cohesion | 7.078614e-4 |
GO:0051259 | protein oligomerization | 7.195382e-4 |
GO:0007612 | learning | 7.200376e-4 |
GO:0044242 | cellular lipid catabolic process | 7.434434e-4 |
GO:0034097 | response to cytokine stimulus | 7.479658e-4 |
GO:0043624 | cellular protein complex disassembly | 7.584313e-4 |
GO:0001555 | oocyte growth | 7.749875e-4 |
GO:0006887 | exocytosis | 7.884808e-4 |
GO:0001990 | regulation of systemic arterial blood pressure by hormone | 8.036381e-4 |
GO:0010940 | positive regulation of necrotic cell death | 8.166790e-4 |
GO:0001955 | blood vessel maturation | 8.166790e-4 |
GO:0046488 | phosphatidylinositol metabolic process | 8.221992e-4 |
GO:0019953 | sexual reproduction | 8.469362e-4 |
GO:0072017 | distal tubule development | 8.585591e-4 |
GO:0051241 | negative regulation of multicellular organismal process | 9.030443e-4 |
GO:0034508 | centromere complex assembly | 9.540064e-4 |
GO:0006810 | transport | 9.571364e-4 |
GO:0071345 | cellular response to cytokine stimulus | 9.620014e-4 |
GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis | 9.754347e-4 |
GO:0042447 | hormone catabolic process | 9.760630e-4 |
GO:0071803 | positive regulation of podosome assembly | 9.769715e-4 |
GO:0060684 | epithelial-mesenchymal cell signaling | 9.836231e-4 |
GO:0009187 | cyclic nucleotide metabolic process | 1.010139e-3 |
GO:0009125 | nucleoside monophosphate catabolic process | 1.026117e-3 |
GO:0043114 | regulation of vascular permeability | 1.029332e-3 |
GO:0050850 | positive regulation of calcium-mediated signaling | 1.069140e-3 |
GO:0046851 | negative regulation of bone remodeling | 1.093014e-3 |
GO:0006273 | lagging strand elongation | 1.096588e-3 |
GO:0006656 | phosphatidylcholine biosynthetic process | 1.105474e-3 |
GO:0007200 | activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger | 1.126509e-3 |
GO:0032729 | positive regulation of interferon-gamma production | 1.138397e-3 |
GO:0033159 | negative regulation of protein import into nucleus, translocation | 1.193956e-3 |
GO:0072218 | metanephric ascending thin limb development | 1.193956e-3 |
GO:0072233 | metanephric thick ascending limb development | 1.193956e-3 |
GO:0060559 | positive regulation of calcidiol 1-monooxygenase activity | 1.193956e-3 |
GO:0045668 | negative regulation of osteoblast differentiation | 1.219380e-3 |
GO:0010517 | regulation of phospholipase activity | 1.256899e-3 |
GO:0014827 | intestine smooth muscle contraction | 1.261762e-3 |
GO:0051272 | positive regulation of cellular component movement | 1.273238e-3 |
GO:0015793 | glycerol transport | 1.276506e-3 |
GO:0034762 | regulation of transmembrane transport | 1.286382e-3 |
GO:0043241 | protein complex disassembly | 1.310429e-3 |
GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway | 1.358460e-3 |
GO:0060248 | detection of cell density by contact stimulus involved in contact inhibition | 1.358460e-3 |
GO:0072285 | mesenchymal to epithelial transition involved in metanephric renal vesicle formation | 1.358460e-3 |
GO:0032620 | interleukin-17 production | 1.358460e-3 |
GO:0002365 | gamma-delta T cell lineage commitment | 1.358460e-3 |
GO:0007371 | ventral midline determination | 1.358460e-3 |
GO:0046903 | secretion | 1.424323e-3 |
GO:0033147 | negative regulation of estrogen receptor signaling pathway | 1.446922e-3 |
GO:0071773 | cellular response to BMP stimulus | 1.481738e-3 |
GO:0071481 | cellular response to X-ray | 1.481738e-3 |
GO:0032411 | positive regulation of transporter activity | 1.518946e-3 |
GO:0071392 | cellular response to estradiol stimulus | 1.519146e-3 |
GO:0071374 | cellular response to parathyroid hormone stimulus | 1.519146e-3 |
GO:0009566 | fertilization | 1.540595e-3 |
GO:0042157 | lipoprotein metabolic process | 1.597817e-3 |
GO:0022616 | DNA strand elongation | 1.605091e-3 |
GO:0071107 | response to parathyroid hormone stimulus | 1.625478e-3 |
GO:0031347 | regulation of defense response | 1.627569e-3 |
GO:0009895 | negative regulation of catabolic process | 1.673085e-3 |
GO:0045060 | negative thymic T cell selection | 1.682280e-3 |
GO:0030335 | positive regulation of cell migration | 1.699751e-3 |
GO:2000147 | positive regulation of cell motility | 1.706051e-3 |
GO:0051583 | dopamine uptake | 1.739786e-3 |
GO:0015747 | urate transport | 1.739786e-3 |
GO:0042993 | positive regulation of transcription factor import into nucleus | 1.755262e-3 |
GO:0006323 | DNA packaging | 1.760284e-3 |
GO:0040017 | positive regulation of locomotion | 1.790728e-3 |
GO:0002863 | positive regulation of inflammatory response to antigenic stimulus | 1.857432e-3 |
GO:0008065 | establishment of blood-nerve barrier | 1.899985e-3 |
GO:0014873 | response to muscle activity involved in regulation of muscle adaptation | 1.899985e-3 |
GO:0061049 | cell growth involved in cardiac muscle cell development | 1.899985e-3 |
GO:0003331 | positive regulation of extracellular matrix constituent secretion | 1.899985e-3 |
GO:0001834 | trophectodermal cell proliferation | 1.899985e-3 |
GO:0002017 | regulation of blood volume by renal aldosterone | 1.899985e-3 |
GO:0015908 | fatty acid transport | 1.916421e-3 |
GO:0050927 | positive regulation of positive chemotaxis | 1.935992e-3 |
GO:0007588 | excretion | 2.057824e-3 |
GO:0007614 | short-term memory | 2.061913e-3 |
GO:0070172 | positive regulation of tooth mineralization | 2.076641e-3 |
GO:0006583 | melanin biosynthetic process from tyrosine | 2.076641e-3 |
GO:0032101 | regulation of response to external stimulus | 2.142453e-3 |
GO:0032722 | positive regulation of chemokine production | 2.182600e-3 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 2.246870e-3 |
GO:0051055 | negative regulation of lipid biosynthetic process | 2.352094e-3 |
GO:0046463 | acylglycerol biosynthetic process | 2.357531e-3 |
GO:0046504 | glycerol ether biosynthetic process | 2.397471e-3 |
GO:0045833 | negative regulation of lipid metabolic process | 2.409909e-3 |
GO:0042476 | odontogenesis | 2.458428e-3 |
GO:0051897 | positive regulation of protein kinase B signaling cascade | 2.475063e-3 |
GO:0051900 | regulation of mitochondrial depolarization | 2.504912e-3 |
GO:0003300 | cardiac muscle hypertrophy | 2.504912e-3 |
GO:0006631 | fatty acid metabolic process | 2.506806e-3 |
GO:0006309 | DNA fragmentation involved in apoptotic nuclear change | 2.568481e-3 |
GO:0043383 | negative T cell selection | 2.572833e-3 |
GO:0016082 | synaptic vesicle priming | 2.595678e-3 |
GO:0032474 | otolith morphogenesis | 2.609940e-3 |
GO:0003106 | negative regulation of glomerular filtration by angiotensin | 2.609940e-3 |
GO:0014895 | smooth muscle hypertrophy | 2.609940e-3 |
GO:0071347 | cellular response to interleukin-1 | 2.619680e-3 |
GO:0051896 | regulation of protein kinase B signaling cascade | 2.638510e-3 |
GO:0003254 | regulation of membrane depolarization | 2.708944e-3 |
GO:0030239 | myofibril assembly | 2.718128e-3 |
GO:0045299 | otolith mineralization | 2.731218e-3 |
GO:0008039 | synaptic target recognition | 2.731218e-3 |
GO:0050901 | leukocyte tethering or rolling | 2.753808e-3 |
GO:0050926 | regulation of positive chemotaxis | 2.773228e-3 |
GO:0071312 | cellular response to alkaloid | 2.802711e-3 |
GO:0060071 | Wnt receptor signaling pathway, planar cell polarity pathway | 2.802711e-3 |
GO:0045948 | positive regulation of translational initiation | 2.859988e-3 |
GO:0045017 | glycerolipid biosynthetic process | 2.862890e-3 |
GO:0009612 | response to mechanical stimulus | 2.869256e-3 |
GO:0003230 | cardiac atrium development | 2.872821e-3 |
GO:0043206 | fibril organization | 2.884942e-3 |
GO:0016554 | cytidine to uridine editing | 2.899463e-3 |
GO:0010572 | positive regulation of platelet activation | 2.899463e-3 |
GO:0006461 | protein complex assembly | 2.906035e-3 |
GO:0051567 | histone H3-K9 methylation | 2.935997e-3 |
GO:0014896 | muscle hypertrophy | 2.961729e-3 |
GO:0006106 | fumarate metabolic process | 2.980818e-3 |
GO:0090200 | positive regulation of release of cytochrome c from mitochondria | 3.039047e-3 |
GO:0002016 | regulation of blood volume by renin-angiotensin | 3.039047e-3 |
GO:0071822 | protein complex subunit organization | 3.052849e-3 |
GO:0032770 | positive regulation of monooxygenase activity | 3.114117e-3 |
GO:0006869 | lipid transport | 3.122644e-3 |
GO:0050848 | regulation of calcium-mediated signaling | 3.158541e-3 |
GO:0042542 | response to hydrogen peroxide | 3.180985e-3 |
GO:0014910 | regulation of smooth muscle cell migration | 3.244308e-3 |
GO:0019605 | butyrate metabolic process | 3.261749e-3 |
GO:0070271 | protein complex biogenesis | 3.287336e-3 |
GO:0019432 | triglyceride biosynthetic process | 3.291449e-3 |
GO:0034763 | negative regulation of transmembrane transport | 3.364592e-3 |
GO:0097012 | response to granulocyte macrophage colony-stimulating factor stimulus | 3.394341e-3 |
GO:0019217 | regulation of fatty acid metabolic process | 3.400743e-3 |
GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin | 3.553254e-3 |
GO:0071310 | cellular response to organic substance | 3.555815e-3 |
GO:0045061 | thymic T cell selection | 3.588500e-3 |
GO:0006897 | endocytosis | 3.594825e-3 |
GO:0010544 | negative regulation of platelet activation | 3.641944e-3 |
GO:0048266 | behavioral response to pain | 3.671669e-3 |
GO:0055088 | lipid homeostasis | 3.720381e-3 |
GO:0048255 | mRNA stabilization | 3.751787e-3 |
GO:0010999 | regulation of eIF2 alpha phosphorylation by heme | 3.781025e-3 |
GO:0009589 | detection of UV | 3.781025e-3 |
GO:0048016 | inositol phosphate-mediated signaling | 3.808930e-3 |
GO:0042761 | very long-chain fatty acid biosynthetic process | 3.847658e-3 |
GO:0030262 | apoptotic nuclear change | 3.867974e-3 |
GO:0030155 | regulation of cell adhesion | 3.875062e-3 |
GO:0035815 | positive regulation of renal sodium excretion | 3.900123e-3 |
GO:0002691 | regulation of cellular extravasation | 3.900123e-3 |
GO:0048840 | otolith development | 3.950995e-3 |
GO:0030730 | sequestering of triglyceride | 3.950995e-3 |
GO:0051532 | regulation of NFAT protein import into nucleus | 3.957689e-3 |
GO:0007265 | Ras protein signal transduction | 3.962102e-3 |
GO:0051234 | establishment of localization | 3.963148e-3 |
GO:0001501 | skeletal system development | 3.971738e-3 |
GO:0042088 | T-helper 1 type immune response | 3.983433e-3 |
GO:0050708 | regulation of protein secretion | 4.054590e-3 |
GO:0060683 | regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling | 4.096705e-3 |
GO:0030970 | retrograde protein transport, ER to cytosol | 4.096705e-3 |
GO:0034389 | lipid particle organization | 4.096705e-3 |
GO:0070848 | response to growth factor stimulus | 4.158525e-3 |
GO:0034694 | response to prostaglandin stimulus | 4.202729e-3 |
GO:0003270 | Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation | 4.292508e-3 |
GO:0014807 | regulation of somitogenesis | 4.292508e-3 |
GO:0014821 | phasic smooth muscle contraction | 4.332166e-3 |
GO:0033622 | integrin activation | 4.388057e-3 |
GO:0051336 | regulation of hydrolase activity | 4.478687e-3 |
GO:0045933 | positive regulation of muscle contraction | 4.509557e-3 |
GO:0003044 | regulation of systemic arterial blood pressure mediated by a chemical signal | 4.522376e-3 |